AAPL345.69+3.69 (+1.08%) ▲|ABBV284.76+1.36 (+0.48%) ▲|ABT104.56-0.12 (-0.11%) ▼|ACN226.79+1.87 (+0.83%) ▲|ADBE245.41-6.26 (-2.49%) ▼|AMAT416.22-13.79 (-3.21%) ▼|AMD540.97-21.26 (-3.78%) ▼|AMGN435.21+1.18 (+0.27%) ▲|AMT184.49+3.13 (+1.73%) ▲|AMZN253.39-1.37 (-0.54%) ▼|AVGO333.96-10.37 (-3.01%) ▼|AXP316.28+2.41 (+0.77%) ▲|BA189.00+0.27 (+0.14%) ▲|BAC52.14+0.44 (+0.85%) ▲|BKNG165.75-0.06 (-0.03%) ▼|BLK1,135.44+14.66 (+1.31%) ▲|BMY60.60+0.03 (+0.05%) ▲|BNY143.30+1.21 (+0.85%) ▲|BRK-B529.60+3.92 (+0.74%) ▲|C125.41+2.20 (+1.78%) ▲|CAT737.56+1.92 (+0.26%) ▲|CL93.70+1.03 (+1.11%) ▲|CMCSA22.25+0.48 (+2.18%) ▲|COF201.81+2.95 (+1.48%) ▲|COP144.70+2.97 (+2.10%) ▲|COST990.58+12.57 (+1.29%) ▲|CRM239.28-7.46 (-3.02%) ▼|CSCO108.10-1.76 (-1.60%) ▼|CVS92.88+0.30 (+0.32%) ▲|CVX222.51+3.19 (+1.45%) ▲|DE641.25-9.42 (-1.45%) ▼|DHR230.18-1.33 (-0.57%) ▼|DIS111.59+0.91 (+0.82%) ▲|DUK120.86+1.98 (+1.67%) ▲|EMR161.70-0.45 (-0.28%) ▼|FDX292.73-2.82 (-0.95%) ▼|GD341.67+4.64 (+1.38%) ▲|GE317.07+5.07 (+1.63%) ▲|GEV928.95+2.51 (+0.27%) ▲|GILD156.37-1.00 (-0.64%) ▼|GM84.92+1.26 (+1.51%) ▲|GOOG339.95-4.96 (-1.44%) ▼|GOOGL343.72-5.50 (-1.57%) ▼|GS890.30-0.98 (-0.11%) ▼|HD312.36+4.12 (+1.34%) ▲|HON211.93+1.43 (+0.68%) ▲|IBM231.76-2.36 (-1.01%) ▼|INTC91.16-4.22 (-4.42%) ▼|INTU323.04-7.13 (-2.16%) ▼|ISRG429.27+1.41 (+0.33%) ▲|JNJ255.45+2.17 (+0.85%) ▲|JPM341.07+5.54 (+1.65%) ▲|KO93.38+1.38 (+1.50%) ▲|LIN498.82+5.60 (+1.14%) ▲|LLY1,262.18+10.57 (+0.84%) ▲|LMT544.12+11.48 (+2.16%) ▲|LOW198.24+2.52 (+1.29%) ▲|LRCX268.61-8.86 (-3.19%) ▼|MA617.04+0.72 (+0.12%) ▲|MCD243.43+0.93 (+0.38%) ▲|MDLZ64.12+1.09 (+1.73%) ▲|MDT94.70-0.75 (-0.79%) ▼|META720.00-16.72 (-2.27%) ▼|MMM164.77-0.57 (-0.34%) ▼|MO74.76+0.92 (+1.24%) ▲|MRK146.74+1.55 (+1.07%) ▲|MS182.61+0.51 (+0.28%) ▲|MSFT528.56-10.88 (-2.02%) ▼|MU895.72-35.52 (-3.81%) ▼|NEE79.92+0.96 (+1.22%) ▲|NFLX70.82-1.79 (-2.47%) ▼|NKE37.44+0.30 (+0.81%) ▲|NOW140.11-8.46 (-5.69%) ▼|NVDA217.01-0.22 (-0.10%) ▼|ORCL129.62-4.86 (-3.61%) ▼|PEP131.21+2.83 (+2.20%) ▲|PFE29.59+0.15 (+0.49%) ▲|PG159.22+2.14 (+1.36%) ▲|PLTR187.33-13.18 (-6.57%) ▼|PM204.24+4.34 (+2.17%) ▲|QCOM176.07-2.33 (-1.31%) ▼|RTX190.95+4.00 (+2.14%) ▲|SBUX97.01+0.13 (+0.13%) ▲|SCHW93.83-0.33 (-0.35%) ▼|SO90.12+0.94 (+1.05%) ▲|SPG205.58+2.19 (+1.08%) ▲|T23.56+0.06 (+0.23%) ▲|TMO686.16-10.33 (-1.48%) ▼|TMUS158.50+1.47 (+0.94%) ▲|TSLA358.11-4.33 (-1.20%) ▼|TXN280.91+1.79 (+0.64%) ▲|UBER71.22-0.05 (-0.07%) ▼|UNH397.50-9.17 (-2.25%) ▼|UNP289.48+0.77 (+0.27%) ▲|UPS99.15+1.32 (+1.35%) ▲|USB58.62+1.23 (+2.13%) ▲|V403.07+3.32 (+0.83%) ▲|VZ44.66+0.26 (+0.57%) ▲|WFC84.08+1.33 (+1.61%) ▲|WMT118.83+0.96 (+0.81%) ▲|XOM175.92+1.24 (+0.71%) ▲|AAPL345.69+3.69 (+1.08%) ▲|ABBV284.76+1.36 (+0.48%) ▲|ABT104.56-0.12 (-0.11%) ▼|ACN226.79+1.87 (+0.83%) ▲|ADBE245.41-6.26 (-2.49%) ▼|AMAT416.22-13.79 (-3.21%) ▼|AMD540.97-21.26 (-3.78%) ▼|AMGN435.21+1.18 (+0.27%) ▲|AMT184.49+3.13 (+1.73%) ▲|AMZN253.39-1.37 (-0.54%) ▼|AVGO333.96-10.37 (-3.01%) ▼|AXP316.28+2.41 (+0.77%) ▲|BA189.00+0.27 (+0.14%) ▲|BAC52.14+0.44 (+0.85%) ▲|BKNG165.75-0.06 (-0.03%) ▼|BLK1,135.44+14.66 (+1.31%) ▲|BMY60.60+0.03 (+0.05%) ▲|BNY143.30+1.21 (+0.85%) ▲|BRK-B529.60+3.92 (+0.74%) ▲|C125.41+2.20 (+1.78%) ▲|CAT737.56+1.92 (+0.26%) ▲|CL93.70+1.03 (+1.11%) ▲|CMCSA22.25+0.48 (+2.18%) ▲|COF201.81+2.95 (+1.48%) ▲|COP144.70+2.97 (+2.10%) ▲|COST990.58+12.57 (+1.29%) ▲|CRM239.28-7.46 (-3.02%) ▼|CSCO108.10-1.76 (-1.60%) ▼|CVS92.88+0.30 (+0.32%) ▲|CVX222.51+3.19 (+1.45%) ▲|DE641.25-9.42 (-1.45%) ▼|DHR230.18-1.33 (-0.57%) ▼|DIS111.59+0.91 (+0.82%) ▲|DUK120.86+1.98 (+1.67%) ▲|EMR161.70-0.45 (-0.28%) ▼|FDX292.73-2.82 (-0.95%) ▼|GD341.67+4.64 (+1.38%) ▲|GE317.07+5.07 (+1.63%) ▲|GEV928.95+2.51 (+0.27%) ▲|GILD156.37-1.00 (-0.64%) ▼|GM84.92+1.26 (+1.51%) ▲|GOOG339.95-4.96 (-1.44%) ▼|GOOGL343.72-5.50 (-1.57%) ▼|GS890.30-0.98 (-0.11%) ▼|HD312.36+4.12 (+1.34%) ▲|HON211.93+1.43 (+0.68%) ▲|IBM231.76-2.36 (-1.01%) ▼|INTC91.16-4.22 (-4.42%) ▼|INTU323.04-7.13 (-2.16%) ▼|ISRG429.27+1.41 (+0.33%) ▲|JNJ255.45+2.17 (+0.85%) ▲|JPM341.07+5.54 (+1.65%) ▲|KO93.38+1.38 (+1.50%) ▲|LIN498.82+5.60 (+1.14%) ▲|LLY1,262.18+10.57 (+0.84%) ▲|LMT544.12+11.48 (+2.16%) ▲|LOW198.24+2.52 (+1.29%) ▲|LRCX268.61-8.86 (-3.19%) ▼|MA617.04+0.72 (+0.12%) ▲|MCD243.43+0.93 (+0.38%) ▲|MDLZ64.12+1.09 (+1.73%) ▲|MDT94.70-0.75 (-0.79%) ▼|META720.00-16.72 (-2.27%) ▼|MMM164.77-0.57 (-0.34%) ▼|MO74.76+0.92 (+1.24%) ▲|MRK146.74+1.55 (+1.07%) ▲|MS182.61+0.51 (+0.28%) ▲|MSFT528.56-10.88 (-2.02%) ▼|MU895.72-35.52 (-3.81%) ▼|NEE79.92+0.96 (+1.22%) ▲|NFLX70.82-1.79 (-2.47%) ▼|NKE37.44+0.30 (+0.81%) ▲|NOW140.11-8.46 (-5.69%) ▼|NVDA217.01-0.22 (-0.10%) ▼|ORCL129.62-4.86 (-3.61%) ▼|PEP131.21+2.83 (+2.20%) ▲|PFE29.59+0.15 (+0.49%) ▲|PG159.22+2.14 (+1.36%) ▲|PLTR187.33-13.18 (-6.57%) ▼|PM204.24+4.34 (+2.17%) ▲|QCOM176.07-2.33 (-1.31%) ▼|RTX190.95+4.00 (+2.14%) ▲|SBUX97.01+0.13 (+0.13%) ▲|SCHW93.83-0.33 (-0.35%) ▼|SO90.12+0.94 (+1.05%) ▲|SPG205.58+2.19 (+1.08%) ▲|T23.56+0.06 (+0.23%) ▲|TMO686.16-10.33 (-1.48%) ▼|TMUS158.50+1.47 (+0.94%) ▲|TSLA358.11-4.33 (-1.20%) ▼|TXN280.91+1.79 (+0.64%) ▲|UBER71.22-0.05 (-0.07%) ▼|UNH397.50-9.17 (-2.25%) ▼|UNP289.48+0.77 (+0.27%) ▲|UPS99.15+1.32 (+1.35%) ▲|USB58.62+1.23 (+2.13%) ▲|V403.07+3.32 (+0.83%) ▲|VZ44.66+0.26 (+0.57%) ▲|WFC84.08+1.33 (+1.61%) ▲|WMT118.83+0.96 (+0.81%) ▲|XOM175.92+1.24 (+0.71%) ▲|
18.5 C
New York
Friday, October 16, 2026

Tag: adults

newssourceFORcompanycontentinformation1releasesmarket

Sebela Pharmaceuticals to Present Positive Phase 3 Tegoprazan Data in Non-Erosive Reflux Disease (NERD) at the American College of Gastroenterology (ACG) 2026 Meeting

Key Highlights:Tegoprazan is the first and only P-CAB reported to demonstrate clinical improvement in both hallmark symptoms of NERD, heartburn and regurgitation, in a...

Celltrion to Present New Analyses of ZYMFENTRA® (infliximab-dyyb) in Crohn’s Disease and Ulcerative Colitis at ACG 2026

New data show favorable outcomes with subcutaneous infliximab following intravenous infliximab interruption, regardless of prior antibody status, in adult patients with moderate to severely...

New Phoenix Scholar issue examining AI, institutional trust and the future of work published by University of Phoenix College of Doctoral Studies

Summer/Fall 2026 issue brings together research on artificial intelligence, career optimism, leadership, education and the human dimensions of technological change. PHOENIX, Oct. 10, 2026...

The Joint Commission has Recognized Genomic Surveillance for the Detection of Transmission in Hospitals

Honors pioneering work at Presbyterian Hospital in Pittsburgh led by members of NGD Infection Prevention's Scientific Advisory BoardCAMBRIDGE, Mass., Oct. 9, 2026 /PRNewswire/ --...

Zenni, Chase Stokes and Bring Change to Mind Support Student Wellness Through Free Vision Care and Mental Health Programming

Partnership provides vision care and styles from Zenni x Chase Stokes collection to nearly 300 New York City high school studentsNEW YORK, Oct. 9,...

US WorldMeds Receives the Sarcoma Foundation of America’s 2026 Vision of Hope Award

Company recognized for advancing treatment options in sarcoma and for embedding the patient advocacy perspective into its development and regulatory workLOUISVILLE, Ky., Oct. 9,...

New Johnson & Johnson ICOTYDE® (icotrokinra) long-term data demonstrate robust 2-year results in the treatment of adults and adolescents with plaque psoriasis

Phase 3 data presented at Fall Clinical Dermatology show high, sustained response rates in adults and adolescents, with nearly three-quarters achieving clear or almost...

Prifemilast Demonstrates Superior Efficacy vs. Apremilast in Newsoara’s Head-to-Head Phase 3 Psoriasis Trial; cAMPfield Advancing the Potential Best-in-Class Oral PDE4 Inhibitor in IBD

In a head-to-head Phase 3 trial, prifemilast nearly doubled the rate of PASI 75 response compared with apremilast and achieved superiority on both co-primary...

Innovent Announces Phase 3 RESTORE-3 Study of SYCUME® (Teprotumumab N01 Injection) Met Primary Endpoint in Inactive Thyroid Eye Disease

SYCUME® Significantly Improved Proptosis (Response Rate 60.4% / LS Mean Change from Baseline -1.88 mm) with Favorable Safety Profile in Participants with Inactive Thyroid...

Aetna 2027 Star Ratings Reflect Strong Clinical Quality and Member Experience

HARTFORD, Conn., Oct 8, 2026 /PRNewswire/ -- Aetna®, a CVS Health® company (NYSE: CVS), announced today that more than 69 percent of its Medicare...

Halloween scares should be spooky, not painful

Orthopaedic surgeons share simple tips to prevent falls, pumpkin-carving injuries and other Halloween mishapsROSEMONT, Ill., Oct. 8, 2026 /PRNewswire/ -- Halloween should be memorable...

Dallas College Expands Bachelor’s Degree Offerings With New Management Program

The move strengthens Dallas' most accessible workforce-aligned pathway to a four-year degree as more than 400 students enroll in the new online program. DALLAS, Oct....

RHONE’S ADULT RECESS BRINGS PLAY TO THE WORKDAY WITH PICK-UP BASKETBALL AT HUDSON YARDS

Adult Recess invites New Yorkers to rediscover PLAY, one of Rhone's 12 Pursuits for living a more active, connected life.NEW YORK, Oct. 8, 2026...

Inglewood Bids to Become America’s Second Blue Zone City, Powered by InBody

CERRITOS, Calif., Oct. 8, 2026 /PRNewswire/ -- InBody today announced the launch of a one-year fall prevention pilot with the City of Inglewood and...

- A word from our sponsors -

spot_img

Newsletter Signup

Name(Required)
Email(Required)
Privacy(Required)
This field is for validation purposes and should be left unchanged.
HomeTagsAdults

Explore

Press Releases

News & Opinion

Living

Others

Follow us

© Copyright 2025. BusinessPressWire® / 14 Wall Street New York City NY 10005 +1 888-502-0266 / Disclaimers